# Preliminary Clinical Study on the Effect of L-ornithine on the Efficacy of Ustekinumab in Patients With Crohn's Disease

> **NCT06455267** · NA · UNKNOWN · sponsor: **The Third Xiangya Hospital of Central South University** · enrollment: 50 (estimated)

## Conditions studied

- Mild to Severe Crohns Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Now Foods L-Ornithine Capsules

## Key facts

- **NCT ID:** NCT06455267
- **Lead sponsor:** The Third Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-09-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06455267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06455267, "Preliminary Clinical Study on the Effect of L-ornithine on the Efficacy of Ustekinumab in Patients With Crohn's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06455267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*